SU2C's Innovative Research Grants (IRGs) support cutting-edge cancer research that might not receive funding through traditional channels. Innovative Research Grants support early-career scientists with novel ideas that have a strong potential to impact patient care - projects that are high-risk but could also be high-impact. In December of 2009, SU2C awarded its first round of IRG grants to thirteen promising researchers, and more recently in April of 2011 another thirteen Innovative Research Grant recipients were selected.
